Evidence map›Paper›PMID 29491142›Full record

ArticleThe Journal of biological chemistry2018

Aspartyl proteases in

Mubashshir Rasheed, Anamika Battu, Rupinder Kaur

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 49 citations in OpenAlex.

  1. Metabolic Responses ofACS omega · 2026
    Article
  2. Journal of medical microbiology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. The GPI-Anchored Aspartyl Proteases Encoded by theJournal of fungi (Basel, Switzerland) · 2025
    Article
  7. mSphere · 2024
    Article
  8. Article
  9. Microbe Profile:Microbiology (Reading, England) · 2024
    Review
  10. Microbiology and molecular biology reviews : MMBR · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Characterization of Aspartic Proteases fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mubashshir RasheedFrom the Centre for DNA Fingerprinting and Diagnostics, Uppal, Hyderabad 500039 and.
Anamika BattuFrom the Centre for DNA Fingerprinting and Diagnostics, Uppal, Hyderabad 500039 and.
Rupinder KaurFrom the Centre for DNA Fingerprinting and Diagnostics, Uppal, Hyderabad 500039 and rkaur@cdfd.org.in.
Centre for DNA Fingerprinting and Diagnostics · IN

Funding

DBT-Wellcome Trust India Alliance IA/S/15/1/501831Wellcome Trust
6 · The paper itself

Abstract

A family of 11 cell surface-associated aspartyl proteases (CgYps1-11), also referred as yapsins, is a key virulence factor in the pathogenic yeast

Indexed as

Immunity, InnateAnimalsAspartic Acid ProteasesCandida glabrataCandidiasisCell SurvivalFemaleFungal ProteinsGene DeletionHumansInterleukin-1betaMacrophagesMiceMice, Inbred BALB CSyk KinaseTHP-1 CellsAspartic Acid ProteasesFungal ProteinsIL1B protein, humanIL1B protein, mouseInterleukin-1betaSyk KinaseSYK protein, humanSyk protein, mousecell wallcell wall remodelingchemotaxisIL-1betainterleukin 1 (IL-1)intracellular survivalmacrophagemouse organ colonizationspleen tyrosine kinase (Syk)SykTHP-1 macrophagesYapsins

Identifiers

PMID29491142
PMCPMC5925793
OpenAlexW2793266396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.